BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17979982)

  • 1. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
    Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
    Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
    Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
    J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
    Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
    BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.
    Heo TH; Lee SM; Bartosch B; Cosset FL; Kang CY
    Virus Res; 2006 Oct; 121(1):58-64. PubMed ID: 16725222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
    Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
    Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
    J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    Cheng JC; Yeh YJ; Pai LM; Chang ML; Yeh CT
    J Med Virol; 2009 Sep; 81(9):1560-8. PubMed ID: 19626614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
    Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
    J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
    Goswami R; Ahmed M; Kilkus J; Han T; Dawson SA; Dawson G
    J Neurosci Res; 2005 Jul; 81(2):208-17. PubMed ID: 15929065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early steps of the hepatitis C virus life cycle.
    Dubuisson J; Helle F; Cocquerel L
    Cell Microbiol; 2008 Apr; 10(4):821-7. PubMed ID: 18081727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-1 and its potential role in HCV entry: another piece of the puzzle.
    Hamilton JP; Thuluvath PJ
    J Clin Gastroenterol; 2008 Jan; 42(1):3-4. PubMed ID: 18097281
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells.
    Marco C; Jiménez-López JM; Ríos-Marco P; Segovia JL; Carrasco MP
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1296-303. PubMed ID: 19084611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity and complexity of ceramide generation after exposure of jurkat leukemia cells to irradiation.
    Ardail D; Maalouf M; Boivin A; Chapet O; Bodennec J; Rousson R; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1211-8. PubMed ID: 19251092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
    Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
    PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.